Valuation: Balchem Corporation

Capitalization 5.75B 4.84B 4.42B 4.22B 7.84B 521B 8.1B 51.35B 20.42B 251B 21.56B 21.11B 876B P/E ratio 2025 *
37.7x
P/E ratio 2026 * 34.8x
Enterprise value 5.8B 4.89B 4.46B 4.26B 7.91B 526B 8.18B 51.84B 20.61B 253B 21.76B 21.31B 885B EV / Sales 2025 *
5.62x
EV / Sales 2026 * 5.17x
Free-Float
99.53%
Yield 2025 *
0.57%
Yield 2026 * 0.64%
1 day-0.67%
1 week+2.17%
Current month+4.30%
1 month+11.48%
3 months+12.90%
6 months+10.33%
Current year+15.73%
1 week 169.72
Extreme 169.725
182.42
1 month 157.85
Extreme 157.85
182.42
Current year 152.58
Extreme 152.58
182.42
1 year 139.17
Extreme 139.17
182.42
3 years 110.74
Extreme 110.74
186.03
5 years 109.88
Extreme 109.88
186.03
10 years 56.6
Extreme 56.6001
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 63 2017-03-31
Director TitleAgeSince
Director/Board Member 69 2018-01-31
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Change 5d. change 1-year change 3-years change Capi.($)
-0.67%+2.17%+11.50%+32.70% 5.75B
-0.94%+4.70%+14.75%+105.92% 85.17B
-1.10%-1.17%-20.75%+7.21% 36.57B
-0.57%+1.23%-33.16%-38.15% 32.67B
-0.88%+0.30%-3.32%+39.30% 24.2B
-6.82%-1.00%+87.06%-24.65% 20.03B
-9.41%+1.57%+107.48%-40.76% 18.71B
+0.16%+2.48%-0.70%-7.05% 19.45B
-0.87%+4.53%+20.30%+110.56% 15.83B
+4.12%+0.89%+79.84%-0.66% 14.06B
Average -1.70%+1.80%+26.30%+18.44% 27.24B
Weighted average by Cap. -1.58%+2.14%+16.83%+34.96%

Financials

2025 *2026 *
Net sales 1.03B 870M 794M 758M 1.41B 93.56B 1.46B 9.23B 3.67B 45.07B 3.87B 3.79B 157B 1.1B 926M 845M 806M 1.5B 99.51B 1.55B 9.81B 3.9B 47.94B 4.12B 4.03B 167B
Net income 155M 131M 119M 114M 212M 14.07B 219M 1.39B 552M 6.78B 582M 570M 23.67B 168M 141M 129M 123M 228M 15.18B 236M 1.5B 595M 7.31B 628M 615M 25.54B
Net Debt 54.43M 45.87M 41.86M 39.96M 74.2M 4.93B 76.74M 486M 193M 2.38B 204M 200M 8.3B -66.66M -56.17M -51.26M -48.93M -90.86M -6.04B -93.97M -595M -237M -2.91B -250M -245M -10.16B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,355
Date Price Change Volume
26-02-12 177.48 $ -0.67% 142,181
26-02-11 178.68 $ +2.34% 195,838
26-02-10 174.59 $ +1.33% 168,689
26-02-09 172.29 $ -0.50% 203,111
26-02-06 173.16 $ -0.32% 178,404
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
177.48USD
Average target price
191.00USD
Spread / Average Target
+7.61%

Quarterly revenue - Rate of surprise